RYOIX
Rydex Series Trust Biotechnology Fund Investor Class
$96.35
Rydex Series Trust Biotechnology Fund Investor Class (RYOIX)
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
RYOIX Mutual Fund Chart & Stats
$96.35
At close: 4:00 PM EST- Previous Close
- $96.35
- Sub-Category
- Sector-Specific
- Total Liabilities
- $1.09M
- Last Dividend Ex-Date
- Dec 16, 2025
- Expense Ratio
- 1.38%
- Holding Count
- 70
- Brand
- Rydex Series Funds
- Dividend Yield
- (9.76%)
- Category
- Equity
- Total Assets
- 137.90M
- Shares Outstanding
- N/A
- 52-Week Range
- $72.00 - $100.48
RYOIX Mutual Fund News
RYOIX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| ABBVAbbvie | 8.17% |
| AMGNAmgen Inc | 5.05% |
| GILDGilead Sciences | 4.49% |
| VRTXVertex Pharmaceuticals Inc. | 4.32% |
| REGNRegeneron Pharmaceuticals | 2.93% |
| RVMDRevolution Medicines, Inc. | 2.48% |
| ALNYAlnylam Pharmaceuticals | 2.36% |
| ONCBeOne Medicines | 2.17% |
| MRNAModerna | 2.15% |
| BIIBBiogen Inc. | 2.13% |
| Total | 36.24% |
Recently Viewed
No data currently available






